Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Curevac N.V.
(NQ:
CVAC
)
3.240
-0.010 (-0.31%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Curevac N.V.
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Can CureVac Recover After Its Vaccine Setback?
July 03, 2021
Investors' dreams of a third strong mRNA vaccine may be over.
Via
The Motley Fool
Topics
Cannabis
Exposures
COVID-19
Cannabis
58 Biggest Movers From Yesterday
July 02, 2021
Gainers The Glimpse Group, Inc. (NASDAQ: VRAR) shares jumped 152.3% to settle at $17.66 on Thursday after the company priced its IPO at $7 per share. Pop Culture Group Co., Ltd (...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Why CureVac Shares Are Trading Lower Today
June 23, 2021
CureVac BV (NASDAQ:CVAC) shares are trading lower by 3.6% ...
Via
Benzinga
CVAC Stock Price Increases 14%: Why It Happened
June 18, 2021
CureVac BV (NASDAQ:CVAC) shares are trading higher by 14% ...
Via
Benzinga
30 Stocks Moving In Thursday's Mid-Day Session
July 01, 2021
Gainers Pop Culture Group Co., Ltd (NASDAQ: CPOP) shares jumped 104.6% to $62.00. Pop Culture Group shares jumped 405% on Wednesday after the company priced its IPO at $6 per...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Analyzing CureVac's Unusual Options Activity
July 01, 2021
CureVac (NASDAQ:CVAC) shares experienced unusual options activity on Thursday. The stock price moved down to $68.53 following the option alert. Sentiment: BULLISH Option Type:...
Via
Benzinga
20 Stocks Moving in Thursday's Pre-Market Session
July 01, 2021
Gainers Alterity Therapeutics Ltd (NASDAQ: ATHE) shares rose 64% to $2.14 in pre-market trading. Alterity Therapeutics recently said it received EU regulatory guidance for ATH434...
Via
Benzinga
The Daily Biotech Pulse: Spero Spikes On Pfizer Investment, FDA Nod For Jazz, Orchard Signs Licensing Deal, Acumen Pharma Debuts
July 01, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 30) Ambrx Biopharma Inc. (NYSE...
Via
Benzinga
Exposures
Product Safety
A Peek Into The Markets: US Stock Futures Up Ahead Of Initial Jobless Claims Data
July 01, 2021
Pre-open movers U.S. stock futures traded higher in early pre-market trade ahead of initial jobless claims data. The Dow Jones climbed over 200 points on Wednesday, while the S...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
CureVac Stock Drops After Final Results Confirm Its COVID-19 Vaccine Trails Rivals
July 01, 2021
The German biotech company CureVac BV (NASDAQ: CVAC) announced on Wednesday after hours the final results of its late-stage COVID-19 vaccine trial showing 48%...
Via
Benzinga
Exposures
COVID-19
CureVac Final Data from Phase 2b/3 Trial of First-Generation COVID-19 Vaccine Candidate, CVnCoV, Demonstrates Protection in Age Group of 18 to 60
June 30, 2021
- Unique pivotal study conducted in 10 countries in fast changing variant environment; 15 COVID-19 variant strains present for efficacy analysis; original strain almost completely absent - Statistical...
From
CureVac
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Intellectual Property
Legal
CureVac Announces Appointment of Dr. Malte Greune as Chief Operating Officer and Transition of Dr. Florian von der Mülbe to Lead Accelerated Development of The RNA Printer(R)
June 30, 2021
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / June 30, 2021 / CureVac N.V. (NASDAQ:CVAC), a global clinical-stage biopharmaceutical company developing a new class of transformative medicines based on...
From
CureVac
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Intellectual Property
Legal
June’s Best and Worst Performing Russell 1,000 Stocks
June 29, 2021
The month of June, the second quarter and the first half of 2021 are almost in the bag.
Via
Talk Markets
Without a Coronavirus Vaccine Of Its Own, Is There Any Hope For CureVac Stock?
June 29, 2021
Things are looking bleak right now, but they might improve with enough time.
Via
The Motley Fool
Exposures
COVID-19
CureVac Announces Voting Results of General Meeting
June 25, 2021
TÜBINGEN, GERMANY andBOSTON, MA / ACCESSWIRE / June 25, 2021 / CureVac N.V. (NASDAQ:CVAC), a global clinical-stage biopharmaceutical company developing a new class of transformative medicines based on...
From
CureVac
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Intellectual Property
Legal
CureVac Provides Supervisory Board Update
June 23, 2021
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / June 23, 2021 / CureVac N.V. (NASDAQ:CVAC), a global clinical-stage biopharmaceutical company developing a new class of transformative medicines based on...
From
CureVac
Via
AccessWire
Topics
Intellectual Property
Regulatory Compliance
Exposures
COVID-19
Intellectual Property
Legal
Could CureVac Be a Millionaire-Maker Stock?
June 23, 2021
CureVac's first COVID vaccine candidate disappointed investors. But a second one looks promising.
Via
The Motley Fool
Exposures
COVID-19
How Pfizer and Moderna Could Profit Big-Time From AstraZeneca's and CureVac's Challenges
June 23, 2021
Bad news for AstraZeneca and CureVac should mean more good news for Pfizer and Moderna.
Via
The Motley Fool
Exposures
COVID-19
Europe Purchases Additional 150M Doses Of Moderna COVID-19 Vaccine
June 22, 2021
The European Union has decided to take up an option under a supply contract with Moderna Inc (NASDAQ: MRNA) that allows the bloc to order 150 million...
Via
Benzinga
Exposures
COVID-19
Why Is Everyone Talking About CureVac Stock?
June 21, 2021
This coronavirus vaccine developer just hit a massive stumbling block.
Via
The Motley Fool
Exposures
COVID-19
The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs
June 20, 2021
Biotech stocks came under pressure in the week ended June 18, dragged by the negative sentiment that prevailed in the broader market due to macroeconomic worries. The U.S. Federal...
Via
Benzinga
Exposures
Product Safety
58 Biggest Movers From Friday
June 21, 2021
Gainers CAI International, Inc. (NYSE: CAI) shares surged 46.9% to close at $56.05 on Friday after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc....
Via
Benzinga
Stock Market Rally Shifts To Tech After Fed Meeting; Adobe, Ford In Focus: Weekly Review
June 18, 2021
Techs seized stock market leadership, despite the Fed signaling earlier rate hikes. But many real economy names dived.
Via
Investor's Business Daily
Topics
Economy
Stocks
Exposures
Economy
Fossil Fuels
Interest Rates
32 Stocks Moving In Friday's Mid-Day Session
June 18, 2021
Gainers CAI International, Inc. (NYSE: CAI) shares jumped 46.4% to $55.86 after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc. Sykes Enterprises,...
Via
Benzinga
28 Stocks Moving in Friday's Pre-Market Session
June 18, 2021
Gainers CAI International, Inc. (NYSE: CAI) rose 45.1% to $55.35 in pre-market trading after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc. Geron...
Via
Benzinga
12 Words From CureVac's CEO That Could Mean Billions for Moderna and Pfizer
June 18, 2021
The news may reinforce Moderna's and Pfizer's vaccine-market dominance.
Via
The Motley Fool
Topics
Supply Chain
Exposures
COVID-19
Supply Chain
50 Biggest Movers From Yesterday
June 18, 2021
Gainers Verve Therapeutics, Inc. (NASDAQ: VERV) shares surged 68% to settle at $31.92 on Thursday after the company priced its IPO at $19 per share. Midatech Pharma plc (NASDAQ...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Tesla Partner CureVac Says Will Find 'Sweet Spot' For COVID-19 Vaccine Despite Disappointing Data
June 18, 2021
CureVac N.V.’s (NASDAQ: CVAC) Chief Financial Officer Pierre Kemula is optimistic its COVID-19 vaccine could still be offered to certain age groups or as a booster, the...
Via
Benzinga
Exposures
COVID-19
Mid-Afternoon Market Update: Nasdaq Gains Over 100 Points; CureVac Shares Plummet
June 17, 2021
Toward the end of trading Thursday, the Dow traded down 0.67% to 33,806.27 while the NASDAQ rose 0.91% to 14,167.03. The S&P also fell, dropping 0.02% to 4,222.94. The U.S....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Dow Plummets as Fed Update, Jobless Data Weighs
June 17, 2021
The Federal Reserve's accelerated interest rate timeline and inflation forecast is putting a damper on stocks today, with worse-than-expected weekly jobless claims only adding insult to injury.
Via
Talk Markets
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.